Effect of SUN 1165, a new potent antiarrhythmic agent, on the kinetics of rate-dependent block of na channels and ventricular conduction of extrasystoles

Journal of Cardiovascular Pharmacology

Volumn 11, Issue 4, 1988, Pages 407-412

  Hattori, Yoshikazu ^a   Hidaka, Toshinori ^a   Aisaka, Kazuo ^a   Satoh, Fumio ^a   Ishihara, Takafumi ^a  

^a SUNTORY LTD   (Japan)

Author keywords

Extrasystoles; Rate dependent Vmax block; SUN 1165; Ventricular conduction

Indexed keywords

DISOPYRAMIDE; LORCAINIDE; MEXILETINE; PILZICAINIDE;

ANIMAL CELL; DIAGNOSIS; DRUG THERAPY; GUINEA PIG; HEART MUSCLE CELL; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; NONHUMAN; SODIUM TRANSPORT;

ANIMAL; ANTI-ARRHYTHMIA AGENTS; CARDIAC COMPLEXES, PREMATURE; COMPARATIVE STUDY; DISOPYRAMIDE; GUINEA PIGS; HEART CONDUCTION SYSTEM; HEART VENTRICLE; IN VITRO; ION CHANNELS; LIDOCAINE; MALE; MEXILETINE; PAPILLARY MUSCLES; PIPERIDINES; SODIUM;

EID: 0023870343     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/00005344-198804000-00005     Document Type: Article

References (16)

1. Aisaka K, Hidaka T, Inomata N, Hamasaki S, Ishihara T, Morita M. N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165): a new potent and long-acting antiarrhythmic agent. Arzneimittelforschung Drug Res 1985;35(suppl II): 1239-45.
2. Hattori Y, Inomata N, Aisaka K, Ishihara T. Electrophysio-logical actions of N-(2,6-dimethylphenyl)-8-pyrrolizidine-acetamide hydrochloride hemihydrate (SUN 1165), a new antiarrhythmic agent. J Cardiovasc Pharmacol 1986;8:998-1002.
3. Inomata N, Ishihara T, Akaike N. SUN 1165, a new antiarrhythmic Na current blocker in ventricular myocites of guinea pig. Comp Biochem Physiol 1987;87C:237-43.
4. Hidaka T, Hamasaki S, Aisaka K, Ishihara T, et al. N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165), a new antiarrhythmic agent: Effect on cardiac conduction. Arzneimittel for schung Drug Res 1985;35(suppl. II):1381-6.
5. Clarkson CW, Hondeghem LM. Evidence for a specific receptor site for lidocaine, quinidine and bupivacaine associated with cardiac sodium channels in guinea pig ventricular myocardium. Cir Res 1985;56:496-506.
6. Campbell TJ. Kinetics of onset of rate-dependent effects of class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea pig ventricle, and provide a theoretical basis for their subclassification. Cardiovasc Res 1983;17:344-52.
7. Campbell TJ. Importance of physico-chemical properties in determining the kinetics of the effects of class I antiarrhythmic drugs on maximum rate of depolarization in guinea pig ventricle. Br J Pharmacol 1983;80:33-40.
8. Courtney KR. Fast frequency-dependent block of action potential upstroke in rabbit atrium by small local anesthetics. Life Sci 1979;24:1581-8.
9. max) in guinea pig ventricular action potentials by mexiletine, disopyramide, and en-cainide. J Cardiovasc Pharmacol 1983;5:291-6.
10. Harrison DC, Winkle RA, Sami M, Mason JW. Encainide: a new and potent antiarrhythmic agent. In: Harrison DC, ed. Cardiac arrhythmias: a decade progress. Boston: GK Hall 1981;315-30.
11. Hondeghem L, Katzung BG. Test of a model of antiarrhythmic drug action. Effects of quinidine and lidocaine on myocardial conduction. Circulation 1980;61:1217-24.
12. Man RYK, Dresel PE. A specific effect of lidocaine and to-cainide on ventricular conduction of mid-range extrasystoles. J Cardiovasc Pharmacol 1979;1:329-42.
13. Blevins RD, Kerin DN, Mathias P, Pesola D, Faitel K, Jar-andilla R, Garfinkel C, Rubenfire M. Intravenous lorcainide versus lidocaine in the treatment of frequent and complex ventricular arrhythmias. Am Heart J 1986;111:447-51.
14. Vlay SC, Mallis GI, Brook S. Intravenous and oral lorcainide: assessment of central nervous system toxicity and antiarrhythmic efficacy. Am Heart J 1986;111:452-5.
15. Anderson JL. Stewart JR, Perry BA, Van Hamersveld DD, Johnston TA, Conard GJ, Chang SF, Kwan DC, Pitt B. Oral flecainide acetate for the treatment of ventricular arrhythmias. N Engl J Med 1981;305:473-7.
16. Flecainide-Quinidine Research Group. Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial. Circulation 1983;67:1117-23.